NEW YORK--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL) announced today that Carl Icahn, Chairman of its Board of Directors, sent the following letter to James Cornelius, Chairman and Chief Executive Officer of Bristol-Myers Squibb Company (NYSE: BMY):
